Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
11.87
-0.06 (-0.50%)
At close: Jun 16, 2025, 3:59 PM
11.91
0.34%
After-hours: Jun 16, 2025, 04:20 PM EDT
-0.50% (1D)
| Bid | 9.5 |
| Market Cap | 904.92M |
| Revenue (ttm) | 56.42M |
| Net Income (ttm) | -208.4M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -4.25 |
| Forward PE | -3.73 |
| Analyst | Buy |
| Ask | 12.47 |
| Volume | 407,729 |
| Avg. Volume (20D) | 996,823 |
| Open | 11.93 |
| Previous Close | 11.93 |
| Day's Range | 11.46 - 11.97 |
| 52-Week Range | 8.18 - 29.56 |
| Beta | 2.16 |
About NRIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+14.21%
Nurix Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
+6.78%
Nurix Therapeutics shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a price target of $35.
2 months ago · seekingalpha.com
Nurix Therapeutics: IRAK4 GS-6971 Isn't Only Protein Degrader With Big PotentialFDA IND clearance given for BTK degrader GS-6791, targeting inflammatory disorders, allowing Nurix Therapeutics, Inc. to receive a $5 million milestone payment from Gilead Sciences. Nurix has earned $...
